News Snapshot:
A technician works at a manufacturing facility of Chinese vaccine maker CanSino Biologics in Tianjin, China November 20, 2018. — Reuters pic BEIJING, Aug 17 — China's vaccine specialist CanSino Biologics Inc has won a patent approval from Beijing for its Covid-19 vaccine candidate Ad5-nCOV, state media reported, citing documents from the country's intellectual property regulator. It is the first Covid-19 vaccine patent granted by China, state-owned newspaper People's Daily reported yesterday. The paper cited documents published by China's National Intellectual Property Administration saying that the patent was issued on Aug. 11. Saudi Arabia said this month it plans to...
